Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
(HD)IVACOV Trial
NCT04712279Phase 3Unknown
- Sponsor
- Corpometria Institute
- Start
- Jan 2021
- Primary completion
- Mar 2021
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ivermectin in coronavirus disease 2019 (COVID-19), sponsored by Corpometria Institute. Status: unknown.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04712279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04712279.